StockData

Anika Therapeutics vs Sanara MedTech

ANIK and SMTI side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ANIK and SMTI compare

Sanara MedTech is the larger company, worth 1.7 times as much as Anika Therapeutics ($301M against $172M).

Sanara MedTech grew revenue faster over the last twelve months (13.0% versus 5.3% for Anika Therapeutics).

Anika Therapeutics keeps more of each dollar of sales as profit, with a net margin of −3.1% compared with −29.2% at Sanara MedTech.

Anika Therapeutics scores higher on the StockData Score (11 against 6 for Sanara MedTech), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricANIKSMTI
Size and price
Market cap$172M$301M
Share price$12.85$32.73
Change, 1 year28.6%51.9%
Change, 5 years−67.6%14.2%
Beta (5Y)1.061.43
Employees235108
StockData Score
Total score11 (better)6
Valuation score1 (better)0
Growth score13 (better)
Performance score3 (better)1
Health score6 (better)2
Dividend score00
Valuation
P/S1.4× (better)2.7×
P/B1.3× (better)37.9×
EV/EBITDA267×30.4× (better)
P/FCF306×66.8× (better)
FCF yield0.33%1.5% (better)
Fair value–$13.42
Margin of safety–−144%
Growth
Revenue growth (TTM)5.3%13.0% (better)
Revenue growth, 5Y average−2.9%45.9% (better)
Profitability
Gross margin62.2%93.0% (better)
Operating margin−4.2%7.7% (better)
Net margin−3.1% (better)−29.2%
FCF margin0.47%4.1% (better)
Return on equity−2.7% (better)−148%
Return on invested capital−4.8%13.1% (better)
Financial health
Debt / equity0.005.85 (better)
Net debt / EBITDA–2.85
Interest coverage–1.2×
Current ratio4.48 (better)2.58
Altman Z-score3.753.76 (better)
Piotroski F-score6 (better)3
Dividends and buybacks
Buyback yield8.8%–
Shareholder yield8.8% (better)0.00%
Ownership
Held by institutions91.9%19.4%
Held by insiders16.9%14.9%
Insider net buying, 12 months$264K–
Short interest, % of float2.9%5.3%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.